The "War on Drugs" just took a massive hit from the Oval Office.
On Saturday, April 18, 2026, President Donald Trump signed a groundbreaking executive order to fast-track federal research into psychedelics like LSD, psilocybin, and ibogaine.
Flanked by military veterans and podcaster Joe Rogan, Trump declared that the era of federal prohibition for these medicines is effectively over.
The high-stakes move wasn't just a political whim.
Trump admitted that Joe Rogan played a pivotal role, privately sending the President information that "checked out" and led to this decisive step.
The goal? To crush the national mental health crisis and stop veterans from fleeing to Mexico for life-saving treatments.
Health Secretary Robert F. Kennedy Jr. was also a major force behind the order, arguing that officials owe it to those struggling with depression and PTSD to "turn over every stone."
Under the new rules, the FDA will move at lightning speed to approve these substances for clinical use.
FDA Commissioner Marty Makary even hinted that some drugs could see approval as early as this summer.
To back this up, the federal government is dumping $50 million into ibogaine research alone.
Navy SEAL legends Marcus Luttrell and Robert O’Neill provided emotional testimonies during the signing, explaining how these "hallucinogens" saved their lives when traditional medicine failed.
While some critics warn that this sends a "dangerous message" and encourages hasty research, the administration is moving forward with a "Make America Healthy Again" energy.
Any drug deemed safe by the FDA will be promptly rescheduled, moving out of the restrictive Category I status and into the hands of those who need it most.